Trial Profile
Study of long-term impact of entecavir use on blood lymphocyte profiles in chronic hepatitis B patients with suboptimal responses to adefovir
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 02 Dec 2015 New trial record